Format

Send to

Choose Destination
Australas J Dermatol. 2015 Aug;56(3):192-6. doi: 10.1111/ajd.12362. Epub 2015 Jun 16.

A case series of 20 women with hidradenitis suppurativa treated with spironolactone.

Author information

1
Department of Dermatology, Royal North Shore Hospital, St Leonards, New South Wales, Australia.
2
Northern Clinical School, University of Sydney, St Leonards, New South Wales, Australia.

Abstract

Hidradenitis suppurativa (HS) is an uncommon chronic skin condition that can range in severity from a single nodule to extensive disease and can have a profound effect on quality of life. Anti-androgen medication has been suggested as a possible management strategy in female patients with HS and is mentioned in review articles as a treatment option. Despite this, there is limited literature documenting the use of anti-androgens in HS. We present our experience with 20 patients with HS treated with oral spironolactone. We advocate spironolactone as a useful, low-cost first-line treatment for women with HS, with relatively few side-effects.

KEYWORDS:

anti-androgen; hidradenitis suppurativa; spironolactone

PMID:
26080895
DOI:
10.1111/ajd.12362
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center